Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Congress Passes Prescription Drug Pricing Reform

Alert

[Updated October 7, 2022]

On Friday, August 12, 2022, the U.S. House of Representatives passed the Inflation Reduction Act (“IRA”), which includes provisions for “Prescription Drug Pricing Reform.” Once implemented, these provisions will represent significant changes to how certain drug products are priced and paid for under Medicare, including by authorizing price-capped “negotiation” for certain high-spend drugs and mandating inflation-based rebates for Medicare utilization. The IRA also redesigns the Medicare Part D benefit to restructure manufacturer, federal government, and plan obligations, as well as set forth cost-sharing limits for patients, among other provisions.

View More

Share links:

Share links:

Related Professionals

Related Practices

Related Industries

Related News & Insights